Heart Disease News and Research

Latest Heart Disease News and Research

New model can eradicate childhood obesity in private sector

Sanofi US and the Alliance for a Healthier Generation, a non-profit organization founded by the American Heart Association and the William J. Clinton Foundation, today announced a new model for the private sector to combat childhood obesity.

16 Jun 2012

Long-term rhythm, not rate, control may prolong life with AF

Rhythm control therapy for atrial fibrillation may improve survival rates compared with rate control therapy when used long term, show study results published in the Archives of Internal Medicine.

15 Jun 2012

Study calls for overhaul in health care practices for elderly prisoners

Soaring numbers of older, sicker prisoners are causing an unprecedented health care challenge for the nation's criminal justice system, according to a new UCSF report.

15 Jun 2012

Better care for dual-eligible Medicare-Medicaid patients could reduce hospitalization rates

Providing better care for dual-eligible Medicare-Medicaid patients could significantly reduce hospitalization rates for this population, saving taxpayers between $625 million and $1.9 billion per year, according to a new study by researchers at RTI International and Florida Atlantic University.

15 Jun 2012

Simple exercise stress test still the most widely used medical test for coronary artery disease

Most people might assume that technology first developed in 1928 would be obsolete by now. But from air conditioned buildings to sliced bread, many inventions of that era are still essential to our lives today. That includes the exercise stress test, which is still the most widely used medical test for coronary artery disease.

15 Jun 2012

New U-M hESC lines now available for federally-funded research

Six new human embryonic stem cell lines derived at the University of Michigan have just been placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research.

15 Jun 2012

Sanofi’s insulin glargine delays progression from pre-diabetes to T2DM

Sanofi presented results from the landmark ORIGIN trial (Outcome Reduction with Initial Glargine Intervention) at the American Diabetes Association 72nd Scientific sessions. The key findings showed that, compared to standard care, Lantus(insulin glargine [rDNA] injection) had no statistically significant positive or negative impact on cardiovascular (CV) outcomes versus standard care during the study period and that there was no association between insulin glargine use and increased risk of any cancer.

15 Jun 2012

STENTYS initiates enrollment in Self-Apposing Sirolimus-eluting stent trial for heart attack

STENTYS S.A., a medical technology company commercializing the world's first and only Self-Apposing Stent to treat Acute Myocardial Infarction (AMI), announced today that it has enrolled the first patient in its 'APPOSITION IV' clinical study using its new Self-Apposing Sirolimus-eluting stent.

From Medtronic 15 Jun 2012

CardioFocus, CryoLife resolve outstanding patent dispute

CryoLife, Inc., a leading medical device company focused on cardiac and vascular surgery, announced today that it has entered into a settlement agreement with CardioFocus, Inc. ending the outstanding patent dispute between CryoLife's wholly owned subsidiary, Cardiogenesis Corporation, and CardioFocus that was pending in the United States District Court of Massachusetts.

15 Jun 2012

Top five prostate wellness tips

David Samadi, MD, Vice-Chair of Urology at Mount Sinai School of Medicine, knows that many men put off caring for their health, even when they have a family. But just a loving nudge from his family can help keep Dad on track for long-term prostate health, prostate cancer prevention, and prostate cancer awareness.

15 Jun 2012

Transplantation of tissue-engineered vein is a success and offers hope for patients who lack suitable veins for dialysis or bypass surgery

The first biologically tissue-engineered vein grown from a patient’s own stem cells has been successfully transplanted into a 10-year-old girl with portal vein obstruction, dramatically enhancing her quality of life.

15 Jun 2012

Cedrus, Tobii to introduce StimTracker

Tobii Technology, the global leader in eye-tracking and interactive gaze technology, announced today that it has partnered with Cedrus, the leading provider of stimuli and response hardware for psychological studies, to introduce the StimTracker for Tobii TX300 Eye Tracker.

15 Jun 2012

Calcium with vitamin D supplements reduces risk of mortality in seniors

A study recently published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM) suggests that vitamin D-when taken with calcium-can reduce the rate of mortality in seniors, therefore providing a possible means of increasing life expectancy.

15 Jun 2012

Digoxin can protect against high blood pressure and heart failure

An ancient heart drug that's inspired the work of herbalists and poets for centuries may treat a condition that plagues millions of overstressed and overweight Americans today.

15 Jun 2012

CryoLife reaches full settlement in Medafor lawsuit

CryoLife, Inc., a leading medical device company focused on cardiac and vascular surgery, announced today that it has reached full settlement of the outstanding CryoLife, Inc. v. Medafor, Inc. lawsuit that was pending in the Northern District Court of Georgia.

15 Jun 2012

Dietitians now have access to simple genetic test kit from Nutrigenomix

The one-size-fits-all approach to nutritional counselling includes basic advice to eat more whole grains and cut back on sodium. While this guidance is certainly appropriate, it doesn't take into account that these universal nutrition recommendations are not equally useful for every person.

15 Jun 2012

Dexcom G4 system receives CE Mark approval

Dexcom, Inc. today announced that it has received CE Mark approval for its fourth generation continuous glucose monitoring system, the Dexcom G4 system, enabling commercialization of the Dexcom G4 system in the European Union and the countries in Asia and Latin America that recognize the CE Mark.

15 Jun 2012

Minimally invasive procedure to treat high blood pressure

A radically different approach to treating high blood pressure – using a minimally invasive procedure – is being evaluated as part of a Pivotal Phase III 90-site national trial that includes The Carl H. and Edyth Lindner Center for Research and Education at The Christ Hospital.

14 Jun 2012

New scientific findings in anticoagulation for stroke prevention

New scientific findings in anticoagulation for stroke prevention are paving the way for updates to the European Society of Cardiology (ESC) Guidelines for the management of atrial fibrillation.

14 Jun 2012